Medicalgorithmics (LTS:0QR8) Piotroski F-Score: 5 (As of Jun. 30, 2026) — Near Median


LTS:0QR8 Medicalgorithmics SA LTS:0QR8
72 GF Score
Price zł33.07
GF Value zł31.62
! 4 Warning Signs
View Full Analysis

What is Medicalgorithmics Piotroski F-Score?

Medicalgorithmics LTS:0QR8 72 Piotroski F-Score is 5 as of Jun. 30, 2026, which is at its 10-year median of 5.00. GuruFocus rates LTS:0QR8 with a GF Score™ of 72/100 and a GF Value™ of zł31.62. The stock has 4 warning signs investors should review. Among 806 Medical Devices & Instruments companies, Medicalgorithmics ranks better than 65.01% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Medicalgorithmics has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Medicalgorithmics's Piotroski F-Score or its related term are showing as below:

LTS:0QR8' s Piotroski F-Score Range Over the Past 10 Years
Min: 1   Med: 5   Max: 7
Current: 5

During the past 13 years, the highest Piotroski F-Score of Medicalgorithmics was 7. The lowest was 1. And the median was 5.

Medicalgorithmics  (LTS:0QR8) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Medicalgorithmics Piotroski F-Score Related Terms


Medicalgorithmics Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Medicalgorithmics's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicalgorithmics Piotroski F-Score Chart

Medicalgorithmics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.00 6.00 5.00 3.00 5.00

Medicalgorithmics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.00 2.00 3.00 5.00 5.00

LTS:0QR8 vs ABT, SYK, MDT: Piotroski F-Score Comparison

For the Medical Devices subindustry, Medicalgorithmics's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicalgorithmics Piotroski F-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medicalgorithmics's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Medicalgorithmics's Piotroski F-Score falls into.


LTS:0QR8
72GF Score
Medicalgorithmics SA LTS:0QR8
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was -2.493 + -4.055 + -0.937 + -2.148 = zł-9.63 Mil.
Cash Flow from Operations was -3.079 + -0.046 + 1.749 + 1.178 = zł-0.20 Mil.
Revenue was 6.969 + 7.194 + 10.053 + 10.233 = zł34.45 Mil.
Gross Profit was 6.43 + 6.328 + 9.055 + 9.04 = zł30.85 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(104.921 + 104.909 + 105.907 + 108.233 + 111.359) / 5 = zł107.0658 Mil.
Total Assets at the begining of this year (Mar25) was zł104.92 Mil.
Long-Term Debt & Capital Lease Obligation was zł18.56 Mil.
Total Current Assets was zł17.25 Mil.
Total Current Liabilities was zł15.52 Mil.
Net Income was -5.316 + -2.126 + -4.633 + -4.199 = zł-16.27 Mil.

Revenue was 5.908 + 5.212 + 5.865 + 6.769 = zł23.75 Mil.
Gross Profit was 5.049 + 4.843 + 5.106 + 5.524 = zł20.52 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(116.595 + 111.034 + 106.771 + 105.814 + 104.921) / 5 = zł109.027 Mil.
Total Assets at the begining of last year (Mar24) was zł116.60 Mil.
Long-Term Debt & Capital Lease Obligation was zł4.93 Mil.
Total Current Assets was zł19.88 Mil.
Total Current Liabilities was zł11.27 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Medicalgorithmics's current Net Income (TTM) was -9.63. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Medicalgorithmics's current Cash Flow from Operations (TTM) was -0.20. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=-9.633/104.921
=-0.09181193

ROA (Last Year)=Net Income/Total Assets (Mar24)
=-16.274/116.595
=-0.13957717

Medicalgorithmics's return on assets of this year was -0.09181193. Medicalgorithmics's return on assets of last year was -0.13957717. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Medicalgorithmics's current Net Income (TTM) was -9.63. Medicalgorithmics's current Cash Flow from Operations (TTM) was -0.20. ==> -0.20 > -9.63 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=18.561/107.0658
=0.17336068

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=4.931/109.027
=0.04522733

Medicalgorithmics's gearing of this year was 0.17336068. Medicalgorithmics's gearing of last year was 0.04522733. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=17.249/15.52
=1.11140464

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=19.877/11.268
=1.76402201

Medicalgorithmics's current ratio of this year was 1.11140464. Medicalgorithmics's current ratio of last year was 1.76402201. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Medicalgorithmics's number of shares in issue this year was 9.953. Medicalgorithmics's number of shares in issue last year was 9.953. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=30.853/34.449
=0.89561381

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=20.522/23.754
=0.86393871

Medicalgorithmics's gross margin of this year was 0.89561381. Medicalgorithmics's gross margin of last year was 0.86393871. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=34.449/104.921
=0.32833275

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=23.754/116.595
=0.20373086

Medicalgorithmics's asset turnover of this year was 0.32833275. Medicalgorithmics's asset turnover of last year was 0.20373086. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+1+1+0+0+1+1+1
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Medicalgorithmics has an F-score of 5 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 5 mean?
Medicalgorithmics (LTS:0QR8) has a Piotroski F-Score of 5 as of Jun. 30, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Medicalgorithmics and its competitors. This is near median its historical median of 5.00. Over the past decade, Medicalgorithmics' Piotroski F-Score has ranged from 1.00 to 7.00. According to the industry distribution chart, Medicalgorithmics ranks #282 out of 806 companies in the Medical Devices & Instruments industry, placing it in the top 35%.
Is Medicalgorithmics' Piotroski F-Score too high?
Medicalgorithmics' current Piotroski F-Score of 5 is near median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 7.00. The Medical Devices & Instruments industry median Piotroski F-Score is 5.00. Medicalgorithmics' value of 5 is 0% at this industry median. Based on the distribution chart, Medicalgorithmics ranks #282 out of 806 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Medicalgorithmics has a GF Score™ of 72/100, reflecting its overall financial health beyond just this single metric.
How does Medicalgorithmics' Piotroski F-Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medicalgorithmics ranks #282 out of 806 companies for Piotroski F-Score. This puts Medicalgorithmics in the upper half of its industry. The industry median Piotroski F-Score is 5.00. Medicalgorithmics' value of 5 is 0% at this benchmark. Historically, Medicalgorithmics' own Piotroski F-Score has ranged from 1.00 to 7.00 over the past decade. While the company's 10-year median is 5.00 vs. the industry median of 5.00, Medicalgorithmics has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Devices & Instruments company?
The median Piotroski F-Score among Medical Devices & Instruments companies is 5.00, based on 806 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medicalgorithmics's current Piotroski F-Score of 5 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Medicalgorithmics and its competitors. For the Medical Devices & Instruments industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medicalgorithmics's current Piotroski F-Score is 5, which is near median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicalgorithmics stock overvalued right now?
Medicalgorithmics (LTS:0QR8) has a current Piotroski F-Score of 5. The stock's GF Value™ is zł31.62, compared to a current price of zł33.07 — trading 4.6% above its estimated fair value. The current Piotroski F-Score is 5, which is near median its 10-year median of 5.00 and 0% at the Medical Devices & Instruments industry median of 5.00. Medicalgorithmics' overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Medicalgorithmics (LTS:0QR8), the current Piotroski F-Score is 5 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medicalgorithmics (LTS:0QR8) Overvalued in 2026?

Based on GuruFocus' analysis, Medicalgorithmics stock appears to be overvalued. The current stock price of zł33.07 is trading 4.6% above its estimated GF Value™ of zł31.62.

Key valuation signals for LTS:0QR8:

  • Piotroski F-Score: 5 (near median its 10-year median of 5.00)
  • GF Value™: zł31.62 vs. price of zł33.07 (4.6% above fair value)
  • GF Score™: 72/100 with 4 warning signs
  • Industry Position: 0% at the Medical Devices & Instruments median (#282 of 806)

No single metric tells the full story. See the LTS:0QR8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medicalgorithmics Business Description

Other Exchanges MDG:Poland
Address Al Jerozolimskie 81, 19 Floor, Central Tower Building, Warsaw, POL, 02-001
Medicalgorithmics SA is a medical technology company. It is engaged in the development of Digital Signal Processing (DSP) algorithms development and software and hardware electronics design for medical applications. The company specializes in providing advance technological solutions in the field of cardiac diagnostics, with a particular focus on ECG signal analysis. The group concentrates on the production and development of its flagship product Pocket ECG - a system for remote monitoring of cardiac arrhythmias. The offered solutions include algorithms and diagnostic systems used in remote heart monitoring. The company operates in Poland, the USA, and other, with majority of revenue from the USA.
72GF Score

Get the complete analysis for LTS:0QR8

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł33.07
Price
zł31.62
GF Value